{
}
At the recent China International Import Expo, multinational medical firms forged partnerships with local entities to enhance China"s healthcare landscape. Notable collaborations included EssilorLuxottica"s agreements to improve optical product manufacturing, Boehringer Ingelheim"s initiative to advance ischemic stroke treatment, and Roche"s launch of a pediatric healthcare exchange platform. Additionally, Shanghai Henlius Biotech partnered with Saudi Arabia"s SVAX to expand its global reach and improve access to affordable medical solutions.
The German ophthalmic devices market is projected to grow at a CAGR of 5.34% from 2023 to 2033, driven by the rising prevalence of eye disorders and an aging population. Key segments include cataract treatments, which are expected to dominate due to high demand for advanced surgical solutions. Recent developments include Carl Zeiss Meditec AG's acquisition of D.O.R.C., enhancing its ophthalmic portfolio.
The French ophthalmic devices market is projected to grow at a CAGR of 4.1% from 2023 to 2033, driven by rising ophthalmic diseases and technological advancements. Key segments include cataract treatments and eye hospitals, with increased mergers and acquisitions expected to enhance facility demand. Major players include Hoya, Alcon, and Bausch Healthcare.
At the 7th China International Import Expo, multinational medical firms forged partnerships with local entities to enhance China's healthcare ecosystem. Notable collaborations included EssilorLuxottica's agreements for intelligent manufacturing, Boehringer Ingelheim's initiative to improve ischemic stroke treatment, and Roche's launch of a pediatric healthcare platform. Additionally, Shanghai Henlius Biotech Inc partnered with Saudi Arabia's SVAX to expand its global market presence.
Meta's Reality Labs reported a $4.4 billion operating loss in the third quarter, despite a 29% year-over-year revenue increase to $270 million. The company continues to invest heavily in augmented and virtual reality technologies, with total losses exceeding $58 billion since 2020. CEO Mark Zuckerberg showcased the Orion AR glasses at the Meta Connect event, aiming to build consumer interest and developer support for future applications.
Meta is set to report its Q3 earnings, with analysts expecting earnings per share of $5.25 and revenue of $40.29 billion, reflecting an 18% year-over-year growth. The company's stock has surged nearly 70% this year, bolstered by strong earnings and significant investments in AI, despite concerns over slowing revenue growth. Meta's Reality Labs division continues to face challenges, with high expenses overshadowing sales, but excitement around its Orion AR glasses and Ray-Ban smart glasses may drive consumer interest.
EssilorLuxottica SA, the leading player in the global eyewear market, has achieved a market value of €100 billion ($108 billion), fulfilling the goal set by its late founder, Leonardo Del Vecchio. This milestone ensures the legacy of the company he built over 60 years ago in the Dolomite mountains.
EssilorLuxottica reported third-quarter 2024 sales of 6,437 million euros, falling 2% short of expectations. UBS maintains a Buy rating with a price target of 232 euros, noting that while growth at constant exchange rates was 4.0%, it raises concerns about margin expansion for the second half of the year. Investors may find fourth-quarter forecasts reassuring despite the challenging environment.
EssilorLuxottica reported third-quarter sales of 6,437 million euros, falling 2% short of forecasts, with constant exchange rate growth at 4.0%. UBS maintains a Buy rating with a price target of 232 euros, suggesting that the promising start to the quarter may bolster the share price despite concerns over margin expansion in the second half of 2024. Investors may find reassurance in fourth-quarter forecasts amid a challenging environment.
UBS maintains a "Buy" rating for EssilorLuxottica following its quarterly results, as reported by Cercle Finance. BOURSORAMA, acting solely as a distribution channel, emphasizes that it has no involvement in the analysis preparation and holds no conflicts of interest regarding the investment recommendations provided.
EssilorLuxottica Société anonyme
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
foreign medical firms forge partnerships to enhance healthcare in china
United States Dollar
Boehringer Ingelheim KG
Shanghai Henlius Biotech, Inc.
Hoffmann-La Roche AG
Fosun Pharma
EssilorLuxottica Société anonyme
DEU
SAU
CHN
Chrystel Barranger
Zhang Wenjie
Show more
02:09 20.11.2024
germany ophthalmic devices market forecast growth driven by aging population and technology
Euro
Carl Zeiss Meditec AG
Topcon Corporation
Metall Zug Ltd.
Alcon Inc.
Bausch & Lomb Corp
EssilorLuxottica Société anonyme
DEU
FRA
Show more
09:40 19.11.2024
growth of ophthalmic devices market in france driven by rising demand
Hoya Company
Bausch Healthcare Inc.
HAAG-Streit Group
Ziemer Ophthalmic Systems AG
EssilorLuxottica Société anonyme
Topcon Company
Carl Zeiss Meditec AG
Johnson et Johnson
Nidek Co. Ltd
Alcon Inc.
FRA
Show more
09:24 19.11.2024
multinational medical firms forge partnerships at china international import expo
United States Dollar
Fosun Pharma
Boehringer Ingelheim KG
EssilorLuxottica Société anonyme
Shanghai Henlius Biotech, Inc.
Hoffmann-La Roche AG
DEU
CHN
SAU
Chrystel Barranger
Zhang Wenjie
Fakeeh Family
Show more
09:17 14.11.2024
meta reports 4.4 billion loss as reality labs unveils orion ar glasses
United States Dollar
Luxottica U.S. Holdings Corp.
Aqua Metals, Inc.
EssilorLuxottica Société anonyme
USA
Mark Zuckerberg
Show more
21:06 30.10.2024
meta prepares to report third quarter earnings amid strong market performance
United States Dollar
Alphabet Inc.
Amazon.com, Inc.
Meta Platforms, Inc.
Microsoft Corporation
EssilorLuxottica Société anonyme
CHN
USA
Jeff Bezos
Barton Crockett
Mark Zuckerberg
Angelo Zino
Show more
17:00 30.10.2024
ray-ban maker achieves 100 billion euro market value fulfilling founder's vision
18:04 22.10.2024
ubs maintains buy rating on essilorluxottica after third quarter results
10:56 18.10.2024
ubs maintains buy rating on essilorluxottica after third quarter results
10:56 18.10.2024
EssilorLuxottica receives Buy rating from UBS after quarterly results
10:50 18.10.2024
Trending
Subcategory
Startups & Entrepreneurship
Industry Trends
Corporate News
Private Equity Deals
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
CEO Changes
Government Economic Policies
Corporate Social Responsibility
Industry Mergers & Acquisitions
Workplace Trends
Energy Sector Developments
Venture Capital Investments
Fintech Startups
Finance Mergers & Acquisitions
AI Innovations
Market Analysis and Predictions
Intellectual Property Laws
Central Bank Actions
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Amazon.com, Inc.
Tesla, Inc.
Salesforce, Inc.
Garuda Aerospace Ltd.
Huawei Technologies CO. Ltd.
Bharti Airtel Ltd.
XPeng Inc.
Microsoft Corporation
Venturewave Capital NO.1 Ltd.
Semler Scientific, Inc.
TENCENT
Wipro Ltd
OpenAI ERC USD
Orange S.A.
IDBI Bank Limited
Standard Chartered Bank
LENOVO GROUP
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Saudi Riyal
Japanese Yen
Malaysian Ringgit
British Pound Sterling
Mexican Peso
Brazilian Real
New Taiwan Dollar
Bahraini Dinar
Qatari Riyal
Pakistani Rupee
Kuwaiti Dinar
Vietnamese Đồng
South Korean Won
Algerian Dinar
People:
Donald Trump
Mark Zuckerberg
Bisrat Degefa
He Xiaopeng
Abdel Fattah El-Sisi
Anmol Singh Jaggi
Puneet Singh Jaggi
Sari Sabban
David Watkins
Simon Moon
Anas Algahtani
Matt Jones
Ayman Hamdan
Elon Musk
Allen Law
Xi Jinping
Anwar Hussain
Sultan Ibrahim ibni Sultan Iskandar
Prashant Joshi
Albinder Dhindsa